The Repair Crew

BPC-157

"The body's tiny repair crew." A short protective protein fragment — only 15 amino acids long — that researchers have studied for decades, mostly in lab animals and cell cultures, for helping tissues heal and protecting cells from damage.

15 amino acids (pentadecapeptide) Found in human stomach juice Studied mostly in vitro / in animals
BPC-157 mascot — a construction-worker character

What it is

BPC-157 is a short protective protein fragment that occurs naturally in human stomach juice. It's only 15 amino acids long, which is why it's sometimes called a "pentadecapeptide." It has been studied for decades — the large majority of that work is in cell cultures and lab animals, not controlled human trials.

How researchers think it works

Unlike a compound that fits one receptor like a key in a single lock, BPC-157 is described in the literature as acting more like a coordinator: it appears to nudge several repair pathways at once. The two cell types that come up most often are endothelial cells (the cells lining blood vessels) and fibroblasts (the cells that build and organise tissue).

Illustrated diagram of BPC-157's proposed mechanism: blood flow & vessel repair via the nitric oxide pathway, new blood vessel growth via VEGFR2, and tissue strength & collagen building.
Conceptual overview. BPC-157 is studied for effects on several cellular repair pathways at once — this is a simplified overview, not a claim of clinical effect.

Blood flow & vessel repair — the nitric oxide (eNOS) pathway

BPC-157 is reported to help endothelial cells produce more nitric oxide. Nitric oxide relaxes blood vessels (improving flow), reduces certain kinds of cellular stress, and supports the growth of tiny new blood vessels where tissue needs them (angiogenesis). In the signaling detail, the Src and caveolin steps are described as freeing up the eNOS enzyme so it can do its job.

New blood-vessel growth — VEGFR2 signaling

BPC-157 is also reported to increase the number and activity of VEGFR2 receptors. VEGFR2 is a key switch for sprouting new capillaries, so an injured area can get fresh oxygen and nutrients faster.

Tissue strength & collagen building — growth-hormone-receptor signaling

In fibroblasts, BPC-157 is described as boosting growth hormone receptors and activating signals such as FAK and ERK. The reported result is better collagen production and more organised repair tissue — scar tissue that behaves more like healthy tissue rather than a weak patch.

What researchers look at

BPC-157 is frequently discussed alongside TB-500, because the two are studied for different parts of the same repair process: BPC-157 more on structural rebuilding and protection, TB-500 more on getting cells and resources moving.

What the evidence does not show. Most published BPC-157 research is in cell cultures and animals. Human clinical evidence is very limited. BPC-157 is not an approved medicine in the United States, and in 2022 the FDA flagged it as a substance it did not consider eligible for pharmacy compounding. Nothing on this page is a recommendation to use it, and no dose is given or implied.

Keep exploring

Peptide Curious provides educational and editorial content only. It is not medical advice and is not a substitute for a qualified healthcare professional. BPC-157 is discussed here as a research compound; content may describe emerging research not approved for clinical use.